Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if cisplatin-based chemotherapy,
cisplatin-gemcitabine-ifosfamide or cisplatin-docetaxel, will improve survival in comparison
to the combination gemcitabine-ifosfamide in patients with advanced NSCLC